RAMM Pharma Corp. (CSE: RAMM)
Canada
· Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Nov 29, 2024, 4:00 PM EST
RAMM Pharma Cash Flow Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | 2018 |
| Net Income | -8.87 | -7.72 | -20.96 | -7.11 | -7.43 | -6.82 | Upgrade
|
| Depreciation & Amortization | 1.15 | 1.34 | 1 | 0.72 | 0.44 | 0.03 | Upgrade
|
| Other Amortization | 0 | - | 0.02 | 0.02 | 0.02 | 3.61 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.03 | -0.02 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.07 | 1.07 | 13.18 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.76 | - | 0.23 | -0.27 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.71 | - | - | Upgrade
|
| Stock-Based Compensation | 0.01 | 0.01 | 0.38 | 0.7 | 4.75 | 0.04 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.08 | -0.01 | 0.07 | 0.1 | 0.02 | 0.14 | Upgrade
|
| Other Operating Activities | 1.28 | 1.29 | 0.09 | 0.34 | -0.46 | 1.01 | Upgrade
|
| Change in Accounts Receivable | 0.39 | 0.51 | 1.51 | -0.22 | 0.83 | -0.4 | Upgrade
|
| Change in Inventory | 0.02 | -0.33 | -0.09 | 0.51 | -0.21 | 0.26 | Upgrade
|
| Change in Accounts Payable | -0.49 | -0.54 | -1.34 | 0.69 | -0.87 | 0.21 | Upgrade
|
| Change in Income Taxes | -0.01 | - | -0 | 0 | 0.01 | 0.11 | Upgrade
|
| Operating Cash Flow | -4.77 | -4.39 | -5.91 | -3.83 | -2.91 | -1.81 | Upgrade
|
| Capital Expenditures | -0.08 | -0.06 | -0.17 | -0.43 | -0.28 | -0.39 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 0.15 | 0.04 | 0.03 | 0.02 | - | Upgrade
|
| Cash Acquisitions | - | - | -1.11 | 3.31 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -1.61 | - | Upgrade
|
| Investment in Securities | - | - | - | -10 | - | - | Upgrade
|
| Other Investing Activities | 0.04 | 0.04 | 0.09 | 0.26 | 0.31 | 0.12 | Upgrade
|
| Investing Cash Flow | 0.1 | 0.13 | -1.15 | -6.83 | -1.56 | -0.27 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 4.33 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 4.33 | Upgrade
|
| Long-Term Debt Repaid | - | -0.24 | -0.13 | -0.08 | -2.36 | -3.1 | Upgrade
|
| Net Debt Issued (Repaid) | -0.22 | -0.24 | -0.13 | -0.08 | -2.36 | 1.23 | Upgrade
|
| Issuance of Common Stock | 0 | - | - | - | - | 3.06 | Upgrade
|
| Repurchase of Common Stock | - | -0.17 | -0.22 | -0.09 | -0.5 | - | Upgrade
|
| Other Financing Activities | 0.01 | - | - | - | -0.05 | 32.13 | Upgrade
|
| Financing Cash Flow | -0.21 | -0.41 | -0.35 | -0.18 | -2.91 | 36.42 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0.01 | 0.04 | -0.01 | 0.02 | 0.11 | Upgrade
|
| Net Cash Flow | -4.84 | -4.66 | -7.38 | -10.85 | -7.36 | 34.45 | Upgrade
|
| Free Cash Flow | -4.84 | -4.45 | -6.08 | -4.26 | -3.19 | -2.2 | Upgrade
|
| Free Cash Flow Margin | -108.37% | -87.86% | -156.02% | -103.52% | -58.61% | -39.15% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.05 | -0.04 | -0.03 | -0.04 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.05 | 0.43 | Upgrade
|
| Levered Free Cash Flow | -2 | -2.31 | -3.79 | -5.03 | -1.88 | 2.53 | Upgrade
|
| Unlevered Free Cash Flow | -1.98 | -2.28 | -3.79 | -5.02 | -1.84 | 2.81 | Upgrade
|
| Change in Net Working Capital | -1.2 | -0.86 | 0.06 | 1.87 | 0.43 | -0.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.